Skip to content
Lower risk Drug recall · FDA · Published November 29, 2021

Leiters Health Moxifloxacin Vials May Contain Wrong Dose - Recall

Leiters Health recalls 10 vials of moxifloxacin 1 mg/mL solution for intracameral injection due to potential label mix-up with 5 mg/mL concentration. This affects prescription-only products sold in the US.

🇺🇸 FDA recall #D-0288-2022DrugLeiters Health ›
Take action

Contact the company

Recalling firmDenver Solutions, LLC DBA Leiters Health13796 Compark Blvd · Englewood, CO 80112-7145
✎ GovInfoNow plain-language explainer

Leiters Health is recalling 10 vials of moxifloxacin 1 mg/mL solution for intracameral injection because vials labeled as 1 mg/mL might actually contain 5 mg/mL. This could lead to incorrect dosing if used without proper verification. Read more at govinfonow.com/recall/35505-leiters-health-moxifloxacin-vials-may-contain-wrong-dose-recall.

Source Summary by GovInfoNow · govinfonow.com/recall/35505-leiters-health-moxifloxacin-vials-may-contain-wrong-dose-recall · Updated August 18, 2026 · FDA enforcement record: FDA #D-0288-2022

Cite this page

“Leiters Health Moxifloxacin Vials May Contain Wrong Dose - Recall.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35505-leiters-health-moxifloxacin-vials-may-contain-wrong-dose-recall. Based on FDA recall #D-0288-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0288-2022%22&limit=1).

The FDA announced on November 29, 2021, that Denver Solutions, LLC DBA Leiters Health recalled Moxifloxacin vials due to a labeling mix-up where 1 mg/mL vials may contain 5 mg/mL. Owners should contact the company at (800) 292-6772 for details.

How to tell if you have it

  • Brand: Leiters Health
  • Product: Moxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/carton, Rx only
  • NDC: 71449-096-42
  • Lot #: 2130958
  • Expiration Date: 03/31/2022

The hazard

The vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL. The FDA classified this recall as Class II.

Context

GovInfoNow's records show Denver Solutions, LLC DBA Leiters Health has had five other recalls since February 21, 2023. Recent recalls include a March 31, 2025 Dexmedetomidine Syringe recall for leaking risk and a February 20, 2024 Moxifloxacin PF Vials recall for glass particulate risk. Other recent recalls of similar products include an April 16, 2026 American Regent Levocarnitine Injection recall for missing label hazard and a February 9, 2026 Meitheal Cetrorelix Acetate Injection Kit recall for missing or duplicated needles.

How to tell if you have this one

Check for Leiters Health product code 13796 on the vial. The product is a prescription-only solution for intracameral injection, sold in 10-vial cartons with NDC 71449-096-42.

  • Brand
    Leiters Health
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Verify Vial Label

    Check the vial label for the concentration (1 mg/mL or 5 mg/mL) before use.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: Nov 29, 202112. FDA classified it Class II: Dec 17, 202123. Published in FDA’s Enforcement Report: Dec 29, 202134. FDA terminated the recall: Jul 12, 2022420212022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product is safe if you verify the concentration on the label before use. However, the labeling error means you should not assume the concentration is correct.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0288-2022 (November 29, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0288-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA